Osaic Holdings
NAVB

Osaic Holdings’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Osaic Holdings’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,150
Closed -$2K – 7840
2021
Q4 		$2K Hold
2,150
– – ﹤0.01% 7114
2021
Q3 		$4K Buy
2,150
+2,000
+1,333% +$3.37K ﹤0.01% 6699
2021
Q2 		$0 Hold
150
– – ﹤0.01% 7346
2021
Q1 		$0 Buy
150
+144
+2,400% +$337 ﹤0.01% 7139
2020
Q4 		$0 Sell
6
-300
-98% -$707 ﹤0.01% 6806
2020
Q3 		$1K Hold
306
– – ﹤0.01% 6161
2020
Q2 		$1K Buy
306
+300
+5,000% +$574 ﹤0.01% 6061
2020
Q1 		$0 Buy
+6
New +$7 ﹤0.01% 6315

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Osaic Holdings's NAVB Position: Q1 2022 in Review

Osaic Holdings sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2022, closing a stake of 2,150 shares — an estimated $2K sold.

Osaic Holdings first reported a position in NAVB in Q1 2020 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 25 funds tracked by Wall St. Rank hold NAVB as of Q1 2022.

  • Osaic Holdings reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Osaic Holdings sold 2,150 Navidea Biopharmaceuticals Inc. shares in Q1 2022, an estimated $2K.
  • Osaic Holdings first reported a position in Navidea Biopharmaceuticals Inc. in Q1 2020 and held it in 8 quarters.
  • Osaic Holdings's Navidea Biopharmaceuticals Inc. position peaked at $4K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2022.

Based on Osaic Holdings's 13F filing for Q1 2022, filed 4 May 2022.